Clinical trial Recruiting at 1 site Early Phase 1 Interventional Ages 18 to 65

Breathing high oxygen levels to improve function after spinal cord injury

Official title: Can Brief Exposure to Hyperoxia Improve Function After Chronic Spinal Cord Injury?

Run by University of Alberta · NCT05467215 · Data updated 2026-11-12

This study is testing if breathing in high levels of oxygen for a short time can help improve movement and feeling in people with serious spinal cord injuries.

Quick facts

PhaseEarly Phase 1
Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment25 (estimated)
SponsorUniversity of Alberta
Academic / other
Locations1 site (Edmonton, Alberta)
StatusRecruiting
StartedJuly 11, 2022
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedSeptember 11, 2026
Trial IDNCT05467215 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 18-65 with traumatic spinal cord injuries that occurred at least three months prior and classified as AIS A, B, or C.

Probably not a fit

Patients with uncontrolled autonomic dysreflexia, significant cardiovascular issues, or severe cognitive impairments may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This proof-of-principle study investigates whether brief exposure to high concentrations of oxygen can enhance sensory and motor functions in individuals with subacute or chronic severe spinal cord injuries. Participants will undergo four experimental sessions where their reflex and sensory functions will be assessed before and after inhaling either room air or 99% oxygen for two minutes. The study aims to determine if this short exposure leads to measurable improvements in function, potentially paving the way for further therapeutic exploration. The safety of high oxygen exposure has been previously established in various injury contexts.

Why it matters

Potential benefit: If successful, this approach could lead to new therapeutic strategies for improving function in patients with spinal cord injuries.

How similar studies have gone: Previous studies have shown that high oxygen exposure can be safe and potentially beneficial in various injury contexts, suggesting a promising avenue for this novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Individuals with traumatic SCI with onset ≥3 months prior,
2. Between 18 - 65 yr old,
3. ASIA Impairment Scale at discharge classified as A, B or C,
4. Injury level between C5 and T10,
5. Able to give informed, written consent.

Exclusion Criteria:

1. Frequent uncontrolled autonomic dysreflexia,
2. Uncontrolled high blood pressure,
3. Cardiac or cardiovascular disease,
4. Cancer,
5. Active urinary tract infection,
6. Active pressure sores,
7. Signs of deep vein thrombosis in the legs,
8. Severe swelling of the feet and/or legs,
9. Severe cognitive impairment,
10. Pulmonary dysfunction such as chronic obstructive pulmonary disease or acute respiratory infection,
11. Any condition which would be exacerbated by sitting or lying in one position for 2 hours, such as low back pain
12. Pregnancy.

Where it's running

  • University of Alberta, Clinical Sciences Bldg
    Edmonton, Alberta, Canada
    Recruiting

Study contacts

  • Principal investigator: Jaynie Yang — University of Alberta
  • Study coordinator: Michelle Barnes, PT
  • Email: carre@ualberta.ca
  • Phone: 780-492-4858

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.